We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
3.4
quarters
Top 10 Avg Time Held
2.1
quarters
Top 20 Avg Time Held
2.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ZVO
1401
DELISTED
Zovio Inc. Common Stock
ZVO
| $27K | ﹤0.01% |
+2,000
| New | +$29K |
2014 Q2
0 quarters
|
|
1402
Cameco
CCJ
$37.6B
| $25K | ﹤0.01% |
1,300
| – | – |
2014 Q1
1 quarter
|
|
|
ALO
1403
DELISTED
Alio Gold Inc
ALO
| $24K | ﹤0.01% |
1,360
| – | – |
2013 Q2
4 quarters
|
|
|
KCLI
1404
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
| $23K | ﹤0.01% |
500
| – | – |
2013 Q2
4 quarters
|
|
1405
Malibu Boats
MBUU
$420M
| $20K | ﹤0.01% |
1,000
| – | – |
2014 Q1
1 quarter
|
|
1406
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $20K | ﹤0.01% |
2,765
| – | – |
2013 Q2
4 quarters
|
|
1407
Gold.com Inc
GOLD
$1.17B
| $19K | ﹤0.01% |
+3,462
| New | +$20.2K |
2014 Q2
0 quarters
|
|
|
GKNT
1408
DELISTED
GEEKNET INC COM NEW
GKNT
| $19K | ﹤0.01% |
1,500
| – | – |
2013 Q2
4 quarters
|
|
|
TGA
1409
DELISTED
Transglobe Energy Corp
TGA
| $18K | ﹤0.01% |
2,400
| – | – |
2013 Q2
4 quarters
|
|
|
ACHN
1410
DELISTED
Achillion Pharmaceuticals
ACHN
| $17K | ﹤0.01% |
2,262
-497,738
| -100% | -$1.99M |
2013 Q4
2 quarters
|
|
|
HTM
1411
DELISTED
U.S. Geothermal Inc.
HTM
| $17K | ﹤0.01% |
4,667
| – | – |
2013 Q2
4 quarters
|
|
1412
Tilly's
TLYS
$138M
| $16K | ﹤0.01% |
+2,000
| New | +$20.2K |
2014 Q2
0 quarters
|
|
|
LXFT
1413
DELISTED
Luxoft Holding, Inc.
LXFT
| $14K | ﹤0.01% |
400
| – | – |
2013 Q3
3 quarters
|
|
|
RIC
1414
DELISTED
Richmont Mines Inc.
RIC
| $14K | ﹤0.01% |
10,100
-50,800
| -83% | -$66.1K |
2013 Q2
4 quarters
|
|
1415
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $13K | ﹤0.01% |
1,200
| – | – |
2013 Q2
4 quarters
|
|
1416
Halozyme
HALO
$12.8B
| $12K | ﹤0.01% |
1,200
-64,875
| -98% | -$550K |
2013 Q2
4 quarters
|
|
|
INTX
1417
DELISTED
Intersections, Inc.
INTX
| $11K | ﹤0.01% |
2,300
| – | – |
2013 Q2
4 quarters
|
|
|
LIWA
1418
DELISTED
LIHUA INTL INC COM STK (DE)
LIWA
| $9K | ﹤0.01% |
4,400
| – | – |
2013 Q2
4 quarters
|
|
|
ARAV
1419
DELISTED
Aravive, Inc. Common Stock
ARAV
| $3K | ﹤0.01% |
+17
| New | +$2.93K |
2014 Q2
0 quarters
|
|
1420
Applied Optoelectronics
AAOI
$8.57B
| – | – |
-3,700
| Closed | -$91K | – |
|
1421
Analog Devices
ADI
$196B
| – | – |
-13,000
| Closed | -$691K | – |
|
1422
Sprott Physical Gold and Silver Trust
CEF
$7.26B
| – | – |
-403,300
| Closed | -$5.55M | – |
|
1423
Cognizant
CTSH
$26.8B
| – | – |
-9,500
| Closed | -$481K | – |
|
1424
Cytokinetics
CYTK
$8.8B
| – | – |
-700,000
| Closed | -$6.65M | – |
|
1425
Delta Air Lines
DAL
$53.2B
| – | – |
-4,400
| Closed | -$152K | – |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.